Yan Jian's Nosin asodium injection (SPINRAZA) has been officially approved by the State Drug Administration
-
Last Update: 2020-06-10
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
yesterday (February 28), theof theCompany (http://announced that the Nosina sodium injection (THE U.Sand EU-registered trade name SPINRAZA) has been officially approved by the NationalDrug(http://Regulatory Authority for the treatment of 5q spinal muscular dystrophy (Muscular Spinal Atrophy, sMA)nosin sodium injectionsnosin sodium injections are the firstdrug(http://approved in China for the treatment of SMASMA is the leading genetic cause of infant death, characterized by a dominant, debilitating muscle weaknessNosina sodium injections were approved by the National Drug Administration based on the largest clinical research data in the field of SMA involving more than 300 Patients with infancy and late onsetA GLOBAL CLINICAL STUDY BY THE COMPANY, WHICH IS A COMPANY, HAS ALSO DEMONSTRATED UNPRECEDENTED EFFICACY IN TREATING PRE-SMA SYMPTOMS WITH NOSINA SODIUM INJECTIONSTHE EXPERTS WERE INFANTS WHO WERE UNDER 6 WEEKS OF AGE AT THE TIME OF THEIR FIRST DRUG USE, WHO WERE GENETICALLY DIAGNOSED WITH SMA BUT DID NOT SHOW ANY SYMPTOMS AT THE TIME OF FIRST TREATMENT THE RIGHT STUDY DATA SHOW THAT EARLIER TREATMENT WILL ENABLE INFANTS TO CONTINUE TO ACHIEVE IMPROVED MOTOR FUNCTION PRIOR TO SMA SYMPTOMS AND ACHIEVE EXERCISE MILESTONES CONSISTENT WITH NORMAL INFANT DEVELOPMENT
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
